Published in Nat Med on October 15, 2002
Acquired immunity to malaria. Clin Microbiol Rev (2009) 6.24
A research agenda for malaria eradication: vaccines. PLoS Med (2011) 3.33
Heparan sulfate proteoglycans provide a signal to Plasmodium sporozoites to stop migrating and productively invade host cells. Cell Host Microbe (2007) 2.64
Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. Proc Natl Acad Sci U S A (2005) 2.49
Intravital observation of Plasmodium berghei sporozoite infection of the liver. PLoS Biol (2005) 2.32
Living in the liver: hepatic infections. Nat Rev Immunol (2012) 2.03
Proteomic profiling of Plasmodium sporozoite maturation identifies new proteins essential for parasite development and infectivity. PLoS Pathog (2008) 1.98
Cell-passage activity is required for the malarial parasite to cross the liver sinusoidal cell layer. PLoS Biol (2004) 1.81
The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host. J Exp Med (2011) 1.62
Malaria parasite development in the mosquito and infection of the mammalian host. Annu Rev Microbiol (2009) 1.52
Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate. J Biol Chem (2009) 1.41
Microneme proteins in apicomplexans. Subcell Biochem (2008) 1.40
Malaria parasite pre-erythrocytic stage infection: gliding and hiding. Cell Host Microbe (2008) 1.30
Dynamics of Toxoplasma gondii differentiation. Eukaryot Cell (2004) 1.26
Looking under the skin: the first steps in malarial infection and immunity. Nat Rev Microbiol (2013) 1.20
Temperature shift and host cell contact up-regulate sporozoite expression of Plasmodium falciparum genes involved in hepatocyte infection. PLoS Pathog (2008) 1.19
A long and winding road: the Plasmodium sporozoite's journey in the mammalian host. Parasitol Int (2007) 1.18
Adenylyl cyclase alpha and cAMP signaling mediate Plasmodium sporozoite apical regulated exocytosis and hepatocyte infection. PLoS Pathog (2008) 1.16
Distinct trafficking and localization of STEVOR proteins in three stages of the Plasmodium falciparum life cycle. Infect Immun (2004) 1.14
Plasmodium sporozoite-host interactions from the dermis to the hepatocyte. Curr Opin Microbiol (2009) 1.10
Exoerythrocytic Plasmodium parasites secrete a cysteine protease inhibitor involved in sporozoite invasion and capable of blocking cell death of host hepatocytes. PLoS Pathog (2010) 1.07
Transition of Plasmodium sporozoites into liver stage-like forms is regulated by the RNA binding protein Pumilio. PLoS Pathog (2011) 1.06
Malaria parasite pre-erythrocytic infection: preparation meets opportunity. Cell Microbiol (2012) 1.06
Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one? Infect Immun (2007) 1.05
Exoerythrocytic development of Plasmodium gallinaceum in the White Leghorn chicken. Int J Parasitol (2007) 1.04
Spatial localisation of actin filaments across developmental stages of the malaria parasite. PLoS One (2012) 1.03
Role of host cell traversal by the malaria sporozoite during liver infection. J Exp Med (2013) 1.01
Liver immunology. Compr Physiol (2013) 0.99
Antibodies against MAEBL ligand domains M1 and M2 inhibit sporozoite development in vitro. Infect Immun (2004) 0.98
Migration of Apicomplexa across biological barriers: the Toxoplasma and Plasmodium rides. Traffic (2008) 0.96
The alveolin IMC1h is required for normal ookinete and sporozoite motility behaviour and host colonisation in Plasmodium berghei. PLoS One (2012) 0.95
Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum. Malar J (2014) 0.95
Initiation of Plasmodium sporozoite motility by albumin is associated with induction of intracellular signalling. Int J Parasitol (2009) 0.95
Role of Plasmodium falciparum thrombospondin-related anonymous protein in host-cell interactions. Malar J (2008) 0.88
Immune evasion strategies of pre-erythrocytic malaria parasites. Mediators Inflamm (2014) 0.86
Developmental biology of sporozoite-host interactions in Plasmodium falciparum malaria: implications for vaccine design. Clin Microbiol Rev (2006) 0.81
Survival of protozoan intracellular parasites in host cells. EMBO Rep (2004) 0.79
CDPKs of Cryptosporidium parvum--stage-specific expression in vitro. Parasitol Res (2014) 0.77
Plasmodium Cysteine Repeat Modular Proteins 3 and 4 are essential for malaria parasite transmission from the mosquito to the host. Malar J (2011) 0.75
Expanding the antimalarial toolkit: Targeting host-parasite interactions. J Exp Med (2016) 0.75
The Threshold of Protection from Liver-Stage Malaria Relies on a Fine Balance between the Number of Infected Hepatocytes and Effector CD8+ T Cells Present in the Liver. J Immunol (2017) 0.75
Signaling Strategies of Malaria Parasite for Its Survival, Proliferation, and Infection during Erythrocytic Stage. Front Immunol (2017) 0.75
Parasite packs a punch. Nat Med (2002) 0.75
The silent path to thousands of merozoites: the Plasmodium liver stage. Nat Rev Microbiol (2006) 2.83
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses. J Exp Med (2006) 2.43
Apoptotic Plasmodium-infected hepatocytes provide antigens to liver dendritic cells. J Infect Dis (2005) 2.42
Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology (2009) 1.87
IL-4-secreting CD4+ T cells are crucial to the development of CD8+ T-cell responses against malaria liver stages. Nat Med (2002) 1.86
Malaria blood stage suppression of liver stage immunity by dendritic cells. J Exp Med (2003) 1.78
The myriad roles of cyclic AMP in microbial pathogens: from signal to sword. Nat Rev Microbiol (2011) 1.58
Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation. PLoS Pathog (2010) 1.39
Hepatocyte growth factor and its receptor are required for malaria infection. Nat Med (2003) 1.37
IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain. J Immunol (2012) 1.34
IL-4 receptor expression on CD8+ T cells is required for the development of protective memory responses against liver stages of malaria parasites. J Exp Med (2005) 1.31
Natural immunization against malaria: causal prophylaxis with antibiotics. Sci Transl Med (2010) 1.31
Essential role for IL-27 receptor signaling in prevention of Th1-mediated immunopathology during malaria infection. J Immunol (2010) 1.29
HGF/MET signalling protects Plasmodium-infected host cells from apoptosis. Cell Microbiol (2005) 1.28
Neuropathogenesis of human and murine malaria. Trends Parasitol (2010) 1.24
Macrophage-mediated but gamma interferon-independent innate immune responses control the primary wave of Plasmodium yoelii parasitemia. Infect Immun (2007) 1.19
Oxidative stress early in pregnancy and pregnancy outcome. Free Radic Res (2008) 1.19
Antitrypanosomal lead discovery: identification of a ligand-efficient inhibitor of Trypanosoma cruzi CYP51 and parasite growth. J Med Chem (2013) 1.19
Measures of immune function of wild mice, Mus musculus. Mol Ecol (2010) 1.17
Adenylyl cyclase alpha and cAMP signaling mediate Plasmodium sporozoite apical regulated exocytosis and hepatocyte infection. PLoS Pathog (2008) 1.16
Plasmodium yoelii yoelii 17XNL constitutively expressing GFP throughout the life cycle. Exp Parasitol (2006) 1.16
Activity in vivo of anti-Trypanosoma cruzi compounds selected from a high throughput screening. PLoS Negl Trop Dis (2011) 1.15
Short-lived IFN-γ effector responses, but long-lived IL-10 memory responses, to malaria in an area of low malaria endemicity. PLoS Pathog (2011) 1.15
The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposing. PLoS Negl Trop Dis (2011) 1.14
Identification of three classes of heteroaromatic compounds with activity against intracellular Trypanosoma cruzi by chemical library screening. PLoS Negl Trop Dis (2009) 1.09
Color capable sub-pixel resolving optofluidic microscope and its application to blood cell imaging for malaria diagnosis. PLoS One (2011) 1.09
Uric acid is a mediator of the Plasmodium falciparum-induced inflammatory response. PLoS One (2009) 1.08
Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine. J Immunol (2012) 1.07
Lipoxin a4 increases survival by decreasing systemic inflammation and bacterial load in sepsis. Shock (2011) 1.06
Role of early cell-free DNA levels decrease as a predictive marker of fatal outcome after severe traumatic brain injury. Clin Chim Acta (2012) 1.06
Experimental cerebral malaria progresses independently of the Nlrp3 inflammasome. Eur J Immunol (2010) 1.04
High prevalence of ultrasonographic synovitis and enthesopathy in patients with psoriasis without psoriatic arthritis: a prospective case-control study. Rheumatology (Oxford) (2011) 1.03
Wide field-of-view Talbot grid-based microscopy for multicolor fluorescence imaging. Opt Express (2013) 1.01
Plasmodium-induced inflammation by uric acid. PLoS Pathog (2008) 0.99
Priming of CD8+ T cell responses following immunization with heat-killed Plasmodium sporozoites. Eur J Immunol (2006) 0.98
Invasion of mammalian host cells by Plasmodium sporozoites. Bioessays (2002) 0.98
Chemical attenuation of Plasmodium berghei sporozoites induces sterile immunity in mice. Infect Immun (2008) 0.95
Plasmodium infection and endotoxic shock induce the expansion of regulatory dendritic cells. J Immunol (2008) 0.94
Role of TGF-beta and PGE2 in T cell responses during Plasmodium yoelii infection. Eur J Immunol (2007) 0.94
Heterogeneous and tissue-specific regulation of effector T cell responses by IFN-gamma during Plasmodium berghei ANKA infection. J Immunol (2011) 0.93
Economic evaluation of three populational screening strategies for cervical cancer in the county of Valles Occidental: CRICERVA clinical trial. BMC Health Serv Res (2011) 0.93
Long-lived memory B-cell responses following BCG vaccination. PLoS One (2012) 0.92
Dual effect of Plasmodium-infected erythrocytes on dendritic cell maturation. Malar J (2010) 0.91
Longitudinal evaluation of the effects of alendronate on MRI bone microarchitecture in postmenopausal osteopenic women. Bone (2010) 0.90
Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge. Vaccine (2008) 0.90
Migration through host cells: the first steps of Plasmodium sporozoites in the mammalian host. Cell Microbiol (2004) 0.90
Definitions for the sonographic features of joints in healthy children. Arthritis Care Res (Hoboken) (2015) 0.89
A Plasmodium yoelii soluble factor inhibits the phenotypic maturation of dendritic cells. Malar J (2008) 0.88
Novel 3-nitro-1H-1,2,4-triazole-based compounds as potential anti-Chagasic drugs: in vivo studies. Future Med Chem (2013) 0.88
Plasma uric acid levels correlate with inflammation and disease severity in Malian children with Plasmodium falciparum malaria. PLoS One (2012) 0.88
Malaria inhibits surface expression of complement receptor 1 in monocytes/macrophages, causing decreased immune complex internalization. J Immunol (2013) 0.87
Potent antimalarial and transmission-blocking activities of centanamycin, a novel DNA-binding agent. J Infect Dis (2008) 0.86
Efficient development of plasmodium liver stage-specific memory CD8+ T cells during the course of blood-stage malarial infection. J Infect Dis (2007) 0.86
Transcriptome profile of dendritic cells during malaria: cAMP regulation of IL-6. Cell Microbiol (2007) 0.86
Analysis of three strategies to increase screening coverage for cervical cancer in the general population of women aged 60 to 70 years: the CRICERVA study. BMC Womens Health (2014) 0.85
Plasmodium falciparum-derived uric acid precipitates induce maturation of dendritic cells. PLoS One (2013) 0.83
A potential role for plasma uric acid in the endothelial pathology of Plasmodium falciparum malaria. PLoS One (2013) 0.80
Angiotensin receptors and β-catenin regulate brain endothelial integrity in malaria. J Clin Invest (2016) 0.80
Targeting Plasmodium host cells: survival within hepatocytes. Trends Mol Med (2004) 0.79
A high-efficiency microfluidic device for size-selective trapping and sorting. Lab Chip (2014) 0.79
Detecting minimal traces of DNA using DNA covalently attached to superparamagnetic nanoparticles and direct PCR-ELISA. Biosens Bioelectron (2005) 0.79
Impact of bronchodilator responsiveness on quality of life and exercise capacity in patients with COPD. Respir Care (2013) 0.79
A surprising role for uric acid: the inflammatory malaria response. Curr Rheumatol Rep (2014) 0.79
Use of logistic regression for prediction of the fate of Staphylococcus aureus in pasteurized milk in the presence of two lytic phages. Appl Environ Microbiol (2010) 0.79
A putative kinase-related protein (PKRP) from Plasmodium berghei mediates infection in the midgut and salivary glands of the mosquito. Int J Parasitol (2010) 0.79
Identification of small-molecule inhibitors of Trypansoma cruzi replication. Bioorg Med Chem Lett (2011) 0.78
Brain injury by captive bolt pistol. J Emerg Med (2012) 0.78
Three-dimensional volumetric ultrasound: a valid method for blinded assessment of response to therapy in rheumatoid arthritis. J Rheumatol (2013) 0.77
Inhibition of Plasmodium sporozoites infection by targeting the host cell. Exp Parasitol (2010) 0.76
Interactions between dendritic cells and CD4+ T cells during Plasmodium infection. Malar J (2008) 0.76
Effect of oral bacteria on the mechanical behavior of titanium dental implants. Int J Oral Maxillofac Implants (2012) 0.75
Daily Plasmodium yoelii infective mosquito bites do not generate protection or suppress previous immunity against the liver stage. Malar J (2011) 0.75
New pieces for the malaria liver stage puzzle: where will they fit? Cell Host Microbe (2008) 0.75
Study of apoptosis and related proteins, CRH and hpGH in placentas of newborns small for gestational age (SGA). Pediatr Endocrinol Rev (2009) 0.75
A 24-week pilot study of dual maintenance therapy with raltegravir and lamivudine. AIDS (2019) 0.75
European Union Clinical Trials Register: on the way to more transparency of clinical trial data. Expert Rev Clin Pharmacol (2013) 0.75